NEWSROOM
20487_FP_Header_Newsroom_Website_2400x900px

Quoi de neuf ?

Quoi de neuf en ce moment chez Dr. Falk Pharma AG ? Vous trouverez les actualités, les communiqués de presse, les appels à études et les évènements à venir dans notre Newsroom et sur les réseaux sociaux

Corporate

Partenariat

18.10.2023

Faites notre connaissance et votre contacts de partenariat

En savoir plus

Corporate, Event

EASL Congress 2023

06.06.2023

We look forward to seeing you on exhibition space E1.

En savoir plus

Indication

Eating should be a pleasure

01.06.2023

What does it feel like to eat when you know that each bite will hurt when swallowing?

En savoir plus

Corporate, Indication

EoE Week 2023

15.05.2023

We support this year’s EoE Week in order to help raise awareness for eosinophilic esophagitis.

En savoir plus

Corporate, Event

ESGE Days 2023

19.04.2023

April 20-22,2023 in Dublin

En savoir plus

[Translate to French:]
Corporate, Press release

Management change at Dr. Falk Pharma GmbH

06.04.2023

Kai Pinkernell takes over as Managing Director Science & Innovation.

En savoir plus

[Translate to French:]
Corporate, Indication

Rare Disease Day

28.02.2023

As the experts in digestive and metabolic medicine, our focus is also on rare diseases.

En savoir plus

Corporate, Event

ECCO Congress 2023

22.02.2023

In Copenhagen, Denmark, from March 1 – 4, 2023.

En savoir plus

Press release, Study

Initiation of Phase II Study of naronapride in patients with gastroparesis

15.02.2023

Renexxion Ireland and Dr. Falk Pharma announce that the first patient has been treated

En savoir plus

Corporate

Launch of Dr. Falk Pharma in Italy

01.12.2022

We are pleased to introduce our Italian affiliate!

En savoir plus

Corporate, Press release

Collaboration and Licensing Agreement with Takeda and Zedira

20.10.2022

To Develop First-in-Class Celiac Disease Therapy

En savoir plus

Corporate

Launch of Dr. Falk Pharma in France

07.10.2022

We are pleased to introduce our French affiliate!

En savoir plus

Logo UEG Week
Event

UEG Week 2022

19.09.2022

Join us from October 8 – 11 in Vienna on booth no. 43 or virtually!

En savoir plus

Logo Zedira
Corporate, Press release

NAFLD: Phase 2a proof of concept study of ZED1227

01.07.2022

Dr. Falk Pharma and Zedira announce trial start for the treatment of non-alcoholic fatty liver disease. First patient enrolled in April.

En savoir plus

Press release, Indication

Have difficulty swallowing food?

10.05.2022

Difficulty swallowing and pain while eating may be warning signs of eosinophilic esophagitis (EoE). The first EoE Day will be held on May 22, 2022.

En savoir plus

Corporate, Press release

Response to the Ukraine crisis

18.03.2022

Dr. Falk Pharma supports APOTHEKER HELFEN e.V.

En savoir plus

Corporate, Press release

Future starts here

24.02.2022

Plans for the future Falk Campus in Freiburg-Nord finalized.

En savoir plus